[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2683944B2 - Indirect agglutination immunoassay method and device - Google Patents

Indirect agglutination immunoassay method and device

Info

Publication number
JP2683944B2
JP2683944B2 JP1329556A JP32955689A JP2683944B2 JP 2683944 B2 JP2683944 B2 JP 2683944B2 JP 1329556 A JP1329556 A JP 1329556A JP 32955689 A JP32955689 A JP 32955689A JP 2683944 B2 JP2683944 B2 JP 2683944B2
Authority
JP
Japan
Prior art keywords
particles
magnetic
immunoassay
container
microplate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP1329556A
Other languages
Japanese (ja)
Other versions
JPH03191864A (en
Inventor
智雄 斉藤
幹雄 池田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Priority to JP1329556A priority Critical patent/JP2683944B2/en
Priority to CA002028995A priority patent/CA2028995A1/en
Priority to ES90120939T priority patent/ES2054195T3/en
Priority to KR1019900017534A priority patent/KR940009958B1/en
Priority to DE69007587T priority patent/DE69007587T2/en
Priority to EP90120939A priority patent/EP0426170B1/en
Priority to AU65720/90A priority patent/AU626044B2/en
Publication of JPH03191864A publication Critical patent/JPH03191864A/en
Priority to US08/082,373 priority patent/US6258607B1/en
Application granted granted Critical
Publication of JP2683944B2 publication Critical patent/JP2683944B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は磁性体粒子又は磁性体を含む粒子を用い、抗
原抗体反応を利用した間接凝集免疫測定方法及び装置に
関するものである。
TECHNICAL FIELD The present invention relates to an indirect agglutination immunoassay method and apparatus using an antigen-antibody reaction using magnetic particles or particles containing a magnetic material.

(従来の技術) 免疫測定方法の一つとして、抗原抗体反応によって起
る結合反応を抗原又は抗体を結合させた粒子を用いて感
度を高めて測定する間接凝集反応は、受身凝集反応又は
逆受身凝集反応と呼ばれ多量検体の簡易測定法として広
く実用化されている。
(Prior art) As one of the immunoassay methods, an indirect agglutination reaction in which a binding reaction caused by an antigen-antibody reaction is measured with increased sensitivity using particles bound with an antigen or an antibody is a passive agglutination reaction or a reverse passive reaction. It is called agglutination reaction and has been widely put to practical use as a simple measurement method for a large amount of samples.

(本発明が解決しようとする問題点) 間接凝集反応による免疫測定法は、EIA(酵素免疫測
定法)やRIA(放射免疫測定法)等に比べ操作が簡便で
あり、最終の抗原抗体反応の有無の判定にも特別な機器
を要しない等の特徴がある。
(Problems to be solved by the present invention) The immunoassay by indirect agglutination reaction is easier to operate than EIA (enzyme immunoassay) or RIA (radioimmunoassay), and the final antigen-antibody reaction It has the feature that it does not require any special equipment to judge the presence or absence.

しかしながら、その操作に熟練を要する、あるいは自
動化が困難である等の欠点があり、今もって部分自動化
の域を出ない状態である。
However, there are drawbacks such as the skill required for the operation and the difficulty in automation, and the state is still beyond the scope of partial automation.

また間接凝集法のパターン形成法としては、U字型又
はV字型のマイクロプレートに所定の希釈検体溶液に所
定の試薬粒子液を添加、撹拌後静置し、粒子の沈降パタ
ーンから抗原抗体反応の有無を判断する方法(以下静置
法と省略する)と、V字型のマイクロプレートの底に粒
子を遠心力を用いて強制的に沈降させ、その後マイクロ
プレートを傾斜させた状態に置き、粒子の底からの剥離
状況から抗原抗体反応の有無を判断する方法(以下遠心
法と省略する)とがある。前者の静置法による沈降パタ
ーンから抗原抗体反応の有無を判断する場合には、静置
中の振動によるパターンの乱れ、例えばスリップ現象の
誘発、パターン面積の減少等が起こりやすく自動化を困
難にしていた。更に静置法のもう一つの欠点は、パター
ン形成の完成までに、使用する粒子によっても異なる
が、約0.5乃至3時間もの長時間を要することである。
又後者の遠心法では、遠心機を用いて沈降を数分で行な
い、その後マイクロプレートを傾斜させ数分でパターン
読取りが行なえ、パターン形成中、振動が加わることに
よるパターンの乱れを心配する必要がない等の利点があ
るが、実際上、遠心機を用いて自動的に免疫測定を行な
うことは技術的に困難である。
Further, as a pattern forming method of the indirect agglutination method, a predetermined reagent particle solution is added to a predetermined diluted sample solution in a U-shaped or V-shaped microplate, and the mixture is left standing after stirring. The method of determining the presence or absence (hereinafter abbreviated as a static method) and the method of forcibly settling particles on the bottom of a V-shaped microplate using centrifugal force, and then placing the microplate in an inclined state, There is a method of determining the presence or absence of an antigen-antibody reaction from the state of separation from the bottom of particles (hereinafter abbreviated as centrifugation method). When determining the presence or absence of an antigen-antibody reaction from the settling pattern by the former stationary method, the disturbance of the pattern due to the vibration during stationary, for example, the induction of a slip phenomenon, the reduction of the pattern area, etc., easily occurs and automation is difficult. It was Another disadvantage of the static method is that it takes about 0.5 to 3 hours to complete the pattern formation, depending on the particles used.
In the latter centrifugal method, sedimentation is performed in a few minutes using a centrifuge, the microplate is then tilted and the pattern can be read in a few minutes, and there is no need to worry about disturbance of the pattern due to vibration during pattern formation. Although there are advantages such as not being present, in practice, it is technically difficult to automatically perform an immunoassay using a centrifuge.

また、前記した従来の静置法及び遠心法とも測定に用
いる検体としては、例えば血清、尿、その他体液等を挙
げることができる。従来の方法では、検体は希釈して使
用するものの、血球と血清の分離操作を省き全血液(以
下全血と省略する)を使用すると底面の一点に集中して
沈降パターンを形成するため血液成分が凝集像に大きな
影響を及ぼし間違った判定結果を与えることが知られて
いる。そのため血球と血清との分離する前処理操作が必
須のものとなっている。
In addition, examples of the sample used for the measurement in both the above-mentioned conventional stationary method and centrifugation method include serum, urine, and other body fluids. In the conventional method, although the sample is used by diluting it, if the separation operation of blood cells and serum is omitted and whole blood (hereinafter abbreviated as whole blood) is used, it concentrates on one point on the bottom surface and forms a sedimentation pattern. Is known to have a great influence on the agglutination image and give an incorrect determination result. Therefore, a pretreatment operation for separating blood cells and serum is essential.

さらに、他の免疫測定法例えば、酵素免疫測定法、放
射免疫測定法等においても、血球と血清の分離操作は、
非特異反応を回避するため前処理操作として用いられて
いるのが現状である。
Furthermore, in other immunoassays such as enzyme immunoassay and radioimmunoassay, the procedure for separating blood cells and serum is
At present, it is used as a pretreatment operation to avoid nonspecific reactions.

(問題点を解決するための手段) 本発明の目的は、従来の上記の欠点を回避し、簡便な
さらには間接凝集反応の全過程を自動化した磁気沈降促
進型の間接凝集免疫測定方法及び装置を提供することで
ある。
(Means for Solving Problems) An object of the present invention is to avoid the above-mentioned drawbacks of the related art, and to perform a simple and automated whole process of indirect agglutination reaction. Is to provide.

本発明の磁気沈降促進型の間接凝集免疫測定方法(以
下「凝集免疫測定方法」という)は、試薬として磁性体
粒子又は磁性体を含む粒子を用いて間接凝集反応による
免疫測定系を構成し、反応後該粒子を含む成分を容器底
部に磁力により強制沈降させ、次に該容器を傾斜させ、
沈降粒子の該容器からの剥離状況から免疫反応の有無を
判断する凝集免疫測定方法である。本発明の凝集免疫測
定方法において、磁性体粒子又は磁性体を含む粒子を含
む成分を磁力により強制沈降させるには、電磁石を用い
ても永久磁石を用いてもよい。
The magnetic precipitation promoting type indirect agglutination immunoassay method of the present invention (hereinafter referred to as “aggregation immunoassay method”) comprises an indirect agglutination immunoassay system using magnetic particles or particles containing a magnetic substance as a reagent, After the reaction, the components containing the particles are forcibly settled on the bottom of the container by magnetic force, and then the container is tilted,
This is an agglutination immunoassay method for determining the presence or absence of an immune reaction based on the state of separation of precipitated particles from the container. In the agglutination immunoassay method of the present invention, an electromagnet or a permanent magnet may be used in order to forcibly settle the magnetic particles or the component containing magnetic particles by magnetic force.

本発明の間接凝集免疫測定装置は免疫測定用検体及び
免疫測定用試薬を受容する該免疫測定用試薬の磁性体又
は磁性体を含む粒子を含む成分の沈降を磁力によって強
制沈降させる手段と、該容器を傾斜させた状態に置く手
段とを有するものである。即ち、本発明においては、磁
石を用いた沈降促進台上で磁性体粒子を強制的に沈降さ
せ、容器底面に引き寄せ、あたかも遠心法で沈降させた
のと同じ作用を得ることができる。これにより従来の静
置方で要した時間の三分の一以下の短時間で、しかも振
動等に影響を受けない測定方法と装置を完成することが
できる。
The indirect agglutination immunoassay apparatus of the present invention comprises means for forcibly sedimenting a magnetic substance or a component containing particles containing a magnetic substance of the immunoassay reagent for receiving an immunoassay sample and an immunoassay reagent by magnetic force, And means for placing the container in a tilted state. That is, in the present invention, it is possible to obtain the same effect as if the magnetic particles were forcibly settled on the settling promotion table using a magnet and pulled to the bottom of the container, and settled by the centrifugal method. As a result, it is possible to complete a measuring method and apparatus that are less than one-third of the time required for conventional stationary methods and that are not affected by vibration or the like.

本発明において試薬中に含まれる磁性体としては、底
面に強制的に沈降させるために磁性体の中でも強磁性体
を好適に使用することができる。また本発明において試
薬として使用できる磁性体粒子又は磁性体を含む粒子の
具体例は以下の通りである。
In the present invention, as the magnetic material contained in the reagent, a ferromagnetic material can be preferably used among the magnetic materials in order to forcefully settle on the bottom surface. Specific examples of magnetic particles or particles containing a magnetic material that can be used as a reagent in the present invention are as follows.

磁性体粒子、強磁性体を含んだゼラチン粒子(特開昭
59−195161号参照)、磁性体を血清アルブミン等で被覆
した粒子、同様に合成ポリマーで被覆した粒子、合成ポ
リマー中磁性体を含んだ粒子等である。
Magnetic particles, gelatin particles containing ferromagnetic material
59-195161), particles coated with a magnetic substance such as serum albumin, particles similarly coated with a synthetic polymer, and particles containing a magnetic substance in a synthetic polymer.

本発明の測定に用いる検体としては、従来の静置法及
び遠心法で用いられる血清、尿、体液等の他全血を使用
できる。全血を使用した場合には、間接凝集反応後、磁
性体粒子又は磁性体を含む粒子成分だけを強制沈降させ
るため、血球成分は、容器全体に広がり底面の一点には
磁性体粒子又は磁性体を含む粒子を含む成分のみ選択的
に集中する。このため全血を使用しても磁性体粒子又は
磁性体を含む粒子を含む成分のパターン形成に及ぼす影
響は、事実上無視することができる。また、血球成分に
より容器が全体に赤色に着色し判定しにくい場合には、
プレートの上をフィルターで覆い判定を容易にすること
ができる。フィルターとしては、赤色系に着色したもの
を使用することができ、ガラス、フィルム、セロハン等
より選ぶことができる。
As the sample used for the measurement of the present invention, whole blood such as serum, urine, and body fluid used in the conventional static method and centrifugation method can be used. When whole blood is used, since only magnetic particles or particle components containing magnetic substances are forcibly settled after the indirect agglutination reaction, blood cell components are spread over the entire container, and magnetic particles or magnetic substances are present at one point on the bottom surface. Only the component containing the particles containing is selectively concentrated. Therefore, even if whole blood is used, its effect on the pattern formation of magnetic particles or components containing magnetic particles can be virtually ignored. If the container is colored red due to blood cell components and it is difficult to judge,
The plate can be covered with a filter to facilitate the determination. As the filter, a reddish one can be used, and it can be selected from glass, film, cellophane and the like.

また発明の検体及び試薬を受容する容器としてはプラ
スチック製、例えばポリスチレン樹脂、ABS樹脂又はガ
ラス製のU字型又はV字型の容器等を使用できる。これ
ら容器の大きさは問わないが、大量の検体を処理し、取
り扱いが容易であり、鮮明な像を得るためい、ポリスチ
レン製のV字型マイクロプレートを好適に用いることが
できる。
As the container for receiving the sample and reagent of the invention, a U-shaped or V-shaped container made of plastic, for example, polystyrene resin, ABS resin or glass can be used. The size of these containers is not limited, but V-shaped microplates made of polystyrene can be preferably used because a large amount of specimens can be processed, handling is easy, and a clear image can be obtained.

本発明の凝集免疫測定装置においては、前記の通り、
免疫測定用検体及び免疫測定用試薬を受容するマイクロ
プレート、該試薬の磁性体粒子又は磁性体を含む粒子を
含む成分を磁力により強制沈降させる手段、及び該マイ
クロプレートを傾斜させた状態にする手段とが必須であ
るが、これを全自動の凝集測定装置として実際に使用す
る際には、第1図に示すように、マイクロプレート供給
装置1、検体分注装置2、試薬分注装置3、検体及び試
薬撹拌装置4、マイクロプレート低部に磁性体粒子又は
磁性体を含む粒子を磁力で沈降させる強制沈降促進装置
5、引続いてこれを傾斜した状態に置く傾斜処理装置
6、沈降粒子成分のマイクロプレートからの傾斜による
剥離状況を読取るパターン読取り装置7及び使用済みマ
イクロプレートを回収するマイクロプレート回収装置8
を組合せて構成することができる。第1図に示す構成例
は、本発明の測定装置の一実施例であって、本発明を限
定するものではない。
In the agglutination immunoassay device of the present invention, as described above,
A microplate for receiving an immunoassay sample and an immunoassay reagent, a means for forcibly sedimenting magnetic particles or components containing particles containing a magnetic material of the reagent by magnetic force, and means for tilting the microplate Is essential, but when actually using it as a fully automatic agglutination measuring device, as shown in FIG. 1, a microplate supplying device 1, a sample dispensing device 2, a reagent dispensing device 3, Stirrer for sample and reagent 4, Forced sedimentation promoting device 5 for magnetically settling magnetic particles or particles containing a magnetic substance in the lower part of the microplate, Gradient treatment device 6 for placing the particles in an inclined state, sedimented particle component Pattern reading device 7 for reading the peeling condition of the microplate from the microplate and the microplate collecting device 8 for collecting the used microplate
Can be configured in combination. The configuration example shown in FIG. 1 is an example of the measuring apparatus of the present invention and does not limit the present invention.

本発明について下記に実施例を示して更に詳細に説明
する。
The present invention will be described in more detail with reference to the following examples.

(実施例) 実施例 1 抗ヒトα−フェトプロテイン(AFP)感作
フェリコロイド含有ゼラチン粒子の調製 フェリコロイドを含むゼラチン粒子(平均粒径約3ミ
クロン、特開昭59−195151号参照)に抗ヒトAFP抗体
(ウサギ、DACO)を用い、Barnard等の方法(Clin.Che
m.,27(6)832(1981)に従い、抗ヒトAFP感作フェリ
コロイド含有ゼラチン粒子を調製した。
(Example) Example 1 Preparation of anti-human α-fetoprotein (AFP) -sensitized ferri colloid-containing gelatin particles Gelatin particles containing ferri colloid (average particle size of about 3 microns, see JP-A-59-195151) were used as anti-human. Using AFP antibody (rabbit, DACO), Barnard's method (Clin.Che
m., 27 (6) 832 (1981), anti-human AFP-sensitized ferri colloid-containing gelatin particles were prepared.

実施例 2 血清中のAFPの測定 各濃度のAFPを含む検体血清の血清希釈用液で10倍に
希釈し、これをV字型マイクロプレートにとり、これに
実施例1で調製した上記の抗ヒトAFP感作フェリコロイ
ド含有ゼラチン粒子の0.09%含有の分散液25μを加
え、撹拌し、10分間経過後、磁石を用いた沈降促進台に
5分間静置し、その後磁力の影響の無いパターン読取台
でマイクロプレートを約70゜傾け、マイクロプレートの
ウェル底部からの沈降粒子の剥離状況から免疫反応の有
無を判定した。ウェル底部より、沈降粒子の剥離の見ら
れるものを陰性判定、見られないものを陽性判定とし
た。
Example 2 Measurement of AFP in Serum Sample serum containing each concentration of AFP was diluted 10-fold with a serum-diluting solution, placed on a V-shaped microplate, and the above-described anti-human prepared in Example 1 was added thereto. AFP-sensitized ferri colloid-containing gelatin particles containing 0.09% dispersion 25μ was added, stirred, and allowed to stand for 10 minutes on a sedimentation accelerating table using a magnet for 5 minutes, after which the pattern reading table was not affected by magnetic force. The microplate was tilted at about 70 ° and the presence or absence of an immune reaction was determined from the state of separation of sedimented particles from the bottom of the well of the microplate. From the bottom of the well, those in which the separation of the sedimented particles was observed were determined as negative, and those in which they were not observed were determined as positive.

本発明による上記の免疫測定方法とセロディア・AFPm
ono(α−フェトプロテイン測定用試薬、富士レビオ株
式会社製)を用いた従来の静置法(従来法)について、
それぞれの力価の相関図を第2図に示す。
The above-mentioned immunoassay method according to the present invention and Cerodia AFPm
Regarding the conventional stationary method (conventional method) using ono (a reagent for measuring α-fetoprotein, manufactured by Fujirebio Inc.),
The correlation diagram of each titer is shown in FIG.

実施例 3 血清中のAFPの測定 AFPを含む検体血清を血清希釈用液で10倍に希釈しこ
れをV字型マイクロプレートの1穴目に50μとり、2
穴目から8穴目まで希釈用液25μを加え、さらに1穴
目より25μとり2穴目から8穴目まで順次2n希釈し
た。これに実施例1で調製した上記の抗ヒトAFP感作フ
ェリコロイド含有ゼラチン粒子の0.14%含有の分散液25
μを加え、3分間撹拌し、磁石を用いた沈降促進台に
3分間静置し、その後磁力の影響の無いパターン読取台
でマイクロプレートを約45゜傾け、マイクロプレートの
ウェル底部からの沈降粒子の剥離状況から免疫反応の有
無を実施例2と同様に判定した。結果を表1に示す。
Example 3 Measurement of AFP in Serum Sample serum containing AFP was diluted 10-fold with a serum-diluting solution, and 50 μm thereof was placed in the first hole of a V-shaped microplate, and 2
25 μl of the diluting solution was added to the 8th to 8th holes, 25 μm was further taken from the 1st hole, and 2n was successively diluted from the 2nd hole to the 8th hole. A dispersion liquid containing 0.14% of the above-mentioned anti-human AFP-sensitized ferricolloid-containing gelatin particles prepared in Example 1 25
Add μ, stir for 3 minutes, and leave it on a sedimentation promotion table using a magnet for 3 minutes. Then, tilt the microplate at about 45 ° with a pattern reading table without the influence of magnetic force, and settle particles from the bottom of the well of the microplate. The presence or absence of an immune reaction was determined in the same manner as in Example 2 from the peeling state of No. Table 1 shows the results.

実施例 4 全血中のAFPの測定 AFPを含む検体血清の血清希釈用液で5倍に希釈した
希釈血清に健常人の全血を等量加え、これをV字型マイ
クロプレート1穴目にとり、実施例3と同様な測定を行
い結果を得た。この結果を表1に示す。
Example 4 Measurement of AFP in whole blood An equal amount of whole blood of a healthy person was added to diluted serum diluted 5 times with a serum-diluting solution of a sample serum containing AFP, and this was taken in the first hole of a V-shaped microplate. The same measurement as in Example 3 was performed and the results were obtained. Table 1 shows the results.

(発明の効果) 本発明の抗原抗体反応の免疫測定方法及び装置におい
ては、磁性体粒子又は磁性体を含む粒子を担体として用
い、これを磁力を用いて容器底部に強制沈降させ、次に
該容器を傾斜させ、沈降粒子容器からの剥離状況から抗
原抗体反応の有無を判定するものであるから、従来の遠
心法と同じ効果を磁性体粒子と磁力で達成でき、従来の
遠心法では困難である全自動化も容易に達成できる。さ
らに従来の静置法よりもはるかに短時間でかつ振動等の
影響を全く受けることなく、又遠心法では全く不可能で
ある全血を用いての測定が可能である。更に本発明の凝
集免疫測定方法と従来の静置法との間には、それぞれの
測定結果に実質的に対応する相関関係があり、従来の静
置法に代えて使用できる。
(Effects of the Invention) In the immunoassay method and apparatus for antigen-antibody reaction of the present invention, magnetic particles or particles containing a magnetic material are used as a carrier, and these are magnetically forced to settle to the bottom of the container. Since the container is tilted and the presence or absence of an antigen-antibody reaction is determined from the state of separation from the sedimented particle container, the same effect as the conventional centrifugation method can be achieved with magnetic particles and magnetic force, which is difficult with the conventional centrifugation method. Some full automation can also be easily achieved. Furthermore, it is possible to perform measurement using whole blood in a much shorter time than the conventional static method, without being affected by vibration at all, and using the whole blood, which is completely impossible by the centrifugation method. Furthermore, the agglutination immunoassay method of the present invention and the conventional static method have a correlation substantially corresponding to each measurement result, and can be used in place of the conventional static method.

また、本発明の方法は、従来の免疫測定法の検体であ
る血清、尿、体液等の他全血を用いての測定も可能であ
り、より簡便な方法を提供する。
In addition, the method of the present invention is also capable of measurement using whole blood such as serum, urine, and body fluid, which are samples of conventional immunoassays, and provides a simpler method.

【図面の簡単な説明】[Brief description of the drawings]

第1図は、本発明による全自動磁気沈降促進型の間接凝
集免疫測定装置の一構成例を示すブロック図、第2図
は、本発明による免疫測定方法と従来の静置法(従来
法)についての、それぞれの力価の相関図である。 1……マイクロプレート供給装置、2……検体分注装
置、3……試薬分注装置、4……検体及び試薬撹拌装
置、5……強制沈降促進装置、6……傾斜処理装置、7
……パターン読取り装置、8……マイクロプレート回収
装置。
FIG. 1 is a block diagram showing an example of the configuration of a fully automatic magnetic precipitation promoting type indirect agglutination immunoassay device according to the present invention, and FIG. 2 is an immunoassay method according to the present invention and a conventional stationary method (conventional method). FIG. 3 is a correlation diagram of each titer of A. 1 ... Microplate supply device, 2 ... Sample dispensing device, 3 ... Reagent dispensing device, 4 ... Sample and reagent stirring device, 5 ... Forced sedimentation promoting device, 6 ... Inclination processing device, 7
...... Pattern reader, 8 ・ ・ ・ Microplate recovery device.

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】磁性体粒子又は磁性体を含む粒子を用いる
間接凝集免疫測定法において (イ)該粒子を容器底部に磁力により強制沈降させる段
階 (ロ)該容器を傾斜させる段階 (ハ)該粒子の該容器底部からの剥離状態を判断する段
階 からなる該測定法。
1. In an indirect agglutination immunoassay method using magnetic particles or particles containing a magnetic material, (a) forcibly settling the particles to the bottom of the container by magnetic force (b) inclining the container (c) The measuring method, which comprises a step of judging the state of separation of particles from the bottom of the container.
【請求項2】検体として全血液を用いてなる、請求項
(1)記載の方法
2. The method according to claim 1, wherein whole blood is used as the sample.
【請求項3】免疫測定用検体及び免疫測定用試薬を受容
する容器と、該免疫測定用試薬の磁性体粒子又は磁性体
を含む粒子を含む成分を沈降を磁力によって強制沈降さ
せる手段と、該容器を傾斜させる手段とを有することを
特徴とする間接凝集免疫測定装置。
3. A container for receiving a sample for immunoassay and a reagent for immunoassay, means for forcibly sedimenting magnetic particles or a component containing particles containing magnetic material of the reagent for immunoassay by magnetic force, An indirect agglutination immunoassay device comprising: a means for tilting the container.
JP1329556A 1989-10-31 1989-12-21 Indirect agglutination immunoassay method and device Expired - Lifetime JP2683944B2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP1329556A JP2683944B2 (en) 1989-12-21 1989-12-21 Indirect agglutination immunoassay method and device
CA002028995A CA2028995A1 (en) 1989-10-31 1990-10-30 Indirect agglutination immunoassay and apparatus therefor
KR1019900017534A KR940009958B1 (en) 1989-10-31 1990-10-31 Indirect agglutination immunoassay and apparatus therefore
DE69007587T DE69007587T2 (en) 1989-10-31 1990-10-31 Indirect agglutination immunodetection method and device therefor.
ES90120939T ES2054195T3 (en) 1989-10-31 1990-10-31 IMMUNOLOGICAL TEST OF INDIRECT AGGLUTINATION AND APPARATUS FOR THE SAME.
EP90120939A EP0426170B1 (en) 1989-10-31 1990-10-31 Indirect agglutination immunoassay and apparatus therefor
AU65720/90A AU626044B2 (en) 1989-10-31 1990-10-31 Indirect agglutination immunoassay and apparatus therefor
US08/082,373 US6258607B1 (en) 1989-10-31 1993-06-28 Indirect agglutination immunoassay and apparatus therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1329556A JP2683944B2 (en) 1989-12-21 1989-12-21 Indirect agglutination immunoassay method and device

Publications (2)

Publication Number Publication Date
JPH03191864A JPH03191864A (en) 1991-08-21
JP2683944B2 true JP2683944B2 (en) 1997-12-03

Family

ID=18222677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1329556A Expired - Lifetime JP2683944B2 (en) 1989-10-31 1989-12-21 Indirect agglutination immunoassay method and device

Country Status (1)

Country Link
JP (1) JP2683944B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011077728A1 (en) * 2009-12-24 2011-06-30 ベックマン コールター, インコーポレイテッド Method for determining hemagglutination image and device for determining hemagglutination image

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05297001A (en) * 1992-04-15 1993-11-12 Fujirebio Inc Method and device for automatic immunity measurement using magnetic particle
JP2809047B2 (en) * 1993-05-17 1998-10-08 富士レビオ株式会社 Indirect agglutination immunoassay and sedimentation pattern measuring device used for the method
JPH06324042A (en) * 1993-05-17 1994-11-25 Fujirebio Inc Method and apparatus for indirectly measuring immunoagglutination

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02107968A (en) * 1988-10-15 1990-04-19 Olympus Optical Co Ltd Immunoassay using magnetic particle
JPH02124464A (en) * 1988-07-20 1990-05-11 Olympus Optical Co Ltd Immunological measuring method using magnetic marker

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02124464A (en) * 1988-07-20 1990-05-11 Olympus Optical Co Ltd Immunological measuring method using magnetic marker
JPH02107968A (en) * 1988-10-15 1990-04-19 Olympus Optical Co Ltd Immunoassay using magnetic particle

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011077728A1 (en) * 2009-12-24 2011-06-30 ベックマン コールター, インコーポレイテッド Method for determining hemagglutination image and device for determining hemagglutination image

Also Published As

Publication number Publication date
JPH03191864A (en) 1991-08-21

Similar Documents

Publication Publication Date Title
US5558839A (en) Magnetic device for immunological analysis of a solid phase
JP5223676B2 (en) Magnetic immunodiagnostic method, especially for the demonstration of the presence of blood group antibody / antigen complexes
US5863802A (en) Method and test kit detecting antigens and/or antibodies
JPS60159651A (en) Analyzing method
JPH01163662A (en) Detection of antigen and/or antibody and test kit for detection
JP4167491B2 (en) Whole blood measurement method
JP2683944B2 (en) Indirect agglutination immunoassay method and device
JP2603843B2 (en) Measuring method of antigen or antibody
AU2660500A (en) Method for detecting antibodies or antigens and for determining blood groups
US6258607B1 (en) Indirect agglutination immunoassay and apparatus therefor
JP2532670B2 (en) Immunological measurement method using magnetic marker particles
JPH08201391A (en) Immunological measuring method with marker grain
EP0426170B1 (en) Indirect agglutination immunoassay and apparatus therefor
JPH03144367A (en) Indirect agglutination immune measuring method and apparatus
JPH08146001A (en) Immunoassay and apparatus
WO1986007463A1 (en) Microtiter - surface - flocculation assay for antigen or antibody screening
JPH07117541B2 (en) Immunological measurement method using magnetic particles
JP2614997B2 (en) Reaction accelerator for agglutination reaction
JP2745705B2 (en) Antigen / antibody assay
JP2009030997A (en) Blood group determining kit for type and screening and blood group determining device using the same
JP2716227B2 (en) Immunological measurement method using magnetic marker particles
CA2495728A1 (en) Method for the detection of antibodies and/or antigens in a test liquid, particularly for determining the blood group
JP2647931B2 (en) Immunological measurement method
JP5047702B2 (en) Red blood cell type determination method
JP2010078374A (en) Method of detecting anti-erythrocyte antibody

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080815

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080815

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090815

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090815

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100815

Year of fee payment: 13

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100815

Year of fee payment: 13